This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Sanofi. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Innovations of Alexandre Benazet
Introduction
Alexandre Benazet is a notable inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic compounds. With a total of 2 patents, his work focuses on innovative solutions for medical applications.
Latest Patents
Benazet's latest patents include "Substituted dimeric quinazoline-2,4-diones as FGF receptor agonists." This invention relates to novel heterocyclic compounds that are pyrazolopyridine derivatives, which induce FGFR dimerization. The compounds have the general formula: M-L-M2, where M and M2 represent monomer units, and L is a linker group that covalently connects them. Additionally, he holds a patent for "Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof." This invention pertains to compounds defined by a specific formula, along with the processes for their preparation and therapeutic applications.
Career Highlights
Benazet is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi emphasizes the importance of innovation in developing new therapeutic agents. His contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Benazet has collaborated with esteemed colleagues, including Nathalie Guillo and Olivier Duclos. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Alexandre Benazet's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents reflect a commitment to advancing medical science through novel compounds and therapeutic strategies. His contributions continue to impact the field positively.